A. HAŞİMİ Et Al. , "Association of serum ADMA, SDMA and L-NMMA concentrations with disease progression in COVID-19 patients," Biochemia Medica , vol.33, no.1, 2023
HAŞİMİ, A. Et Al. 2023. Association of serum ADMA, SDMA and L-NMMA concentrations with disease progression in COVID-19 patients. Biochemia Medica , vol.33, no.1 .
HAŞİMİ, A., DOĞAN, Ö., Serdar, C. C., & SERDAR, M. A., (2023). Association of serum ADMA, SDMA and L-NMMA concentrations with disease progression in COVID-19 patients. Biochemia Medica , vol.33, no.1.
HAŞİMİ, Adnan Et Al. "Association of serum ADMA, SDMA and L-NMMA concentrations with disease progression in COVID-19 patients," Biochemia Medica , vol.33, no.1, 2023
HAŞİMİ, Adnan Et Al. "Association of serum ADMA, SDMA and L-NMMA concentrations with disease progression in COVID-19 patients." Biochemia Medica , vol.33, no.1, 2023
HAŞİMİ, A. Et Al. (2023) . "Association of serum ADMA, SDMA and L-NMMA concentrations with disease progression in COVID-19 patients." Biochemia Medica , vol.33, no.1.
@article{article, author={Adnan HAŞİMİ Et Al. }, title={Association of serum ADMA, SDMA and L-NMMA concentrations with disease progression in COVID-19 patients}, journal={Biochemia Medica}, year=2023}